• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RESONATE X4 CRT-D; CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RESONATE X4 CRT-D; CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR Back to Search Results
Model Number G447
Device Problems Pacing Problem (1439); Inappropriate/Inadequate Shock/Stimulation (1574); Inaccurate Synchronization (1609)
Patient Problems Ventricular Fibrillation (2130); Electric Shock (2554)
Event Date 06/30/2023
Event Type  Injury  
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) was suspected of accelerating rhythm intro ventricular fibrillation after anti-tachycardia pacing (atp) and several shocks.The patient was externally converted on the way to the emergency room.Technical services (ts) was consulted about possible reprogramming options to discriminate atrial fibrillation (af) with rapid ventricular response.Defibrillation threshold (dft) test was not successful.This crt-d remains in service.No additional adverse patient effects were reported.
 
Manufacturer Narrative
The returned device was thoroughly inspected and analyzed upon receipt at our post market quality assurance laboratory.Visual examination of the device header and case noted no anomalies.Dimensional analysis of the header was completed.Each port measured as expected.The device was then exposed to simulated heart load conditions, and the defibrillation, pacing, and sensing functions were tested.Testing measurements were within normal limits excepting shock range which was below specification.Analysis did not identify any device characteristics that would have caused or contributed to the reported clinical observations.
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) was suspected of accelerating rhythm intro ventricular fibrillation after anti-tachycardia pacing (atp) and several shocks.The patient was externally converted on the way to the emergency room.Technical services (ts) was consulted about possible reprogramming options to discriminate atrial fibrillation (af) with rapid ventricular response.Defibrillation threshold (dft) test was not successful.This crt-d remains in service.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESONATE X4 CRT-D
Type of Device
CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key17308877
MDR Text Key318917253
Report Number2124215-2023-36699
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00802526589539
UDI-Public00802526589539
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010012/S436
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 03/04/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date02/08/2024
Device Model NumberG447
Device Catalogue NumberG447
Device Lot Number277445
Was Device Available for Evaluation? Device Returned to Manufacturer
Initial Date Manufacturer Received 07/05/2023
Initial Date FDA Received07/12/2023
Supplement Dates Manufacturer Received02/29/2024
Supplement Dates FDA Received03/04/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/16/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Other;
Patient Age35 YR
Patient SexMale
-
-